Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps
暂无分享,去创建一个
Jun Yu | Jun Yu | J. Sung | S. Ng | F. K. Chan | Yujuan Dong | Joseph J Y Sung | C. W. Lee | Francis K L Chan | Chung Wah Wu | Simon S M Ng | Yu Juan Dong | Siew Chien Ng | Wing Wa Leung | Chung Wa Lee | Yee Ni Wong | C. Wu | S. Ng | W. Leung | Yee Ni C. Wong
[1] Zuoren Yu,et al. The DNA/RNA-binding protein, translin, binds microRNA122a and increases its in vivo stability. , 2008, Journal of andrology.
[2] W. Leung,et al. Detection of Hypermethylated DNA or Cyclooxygenase-2 Messenger RNA in Fecal Samples of Patients With Colorectal Cancer or Polyps , 2007, The American Journal of Gastroenterology.
[3] A. Jemal,et al. Global Cancer Statistics , 2011 .
[4] P. Hardt,et al. Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls. , 2003, Anticancer research.
[5] F. Chan,et al. Asia Pacific consensus recommendations for colorectal cancer screening , 2008, Gut.
[6] C. Fraser,et al. Effect of delay in sampling on haemoglobin determined by faecal immunochemical tests , 2008, Annals of clinical biochemistry.
[7] D. Ransohoff,et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. , 2004, The New England journal of medicine.
[8] Farid E Ahmed,et al. Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue. , 2009, Cancer genomics & proteomics.
[9] S. Bingham,et al. Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool , 2002, The Lancet.
[10] E. Ng,et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening , 2009, Gut.
[11] Loyal A Goff,et al. Differential regulation of microRNA stability. , 2010, RNA.
[12] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[13] Francesco Rulli,et al. Clusterin in Stool: A New Biomarker for Colon Cancer Screening? , 2009, The American Journal of Gastroenterology.
[14] H. Sugimura,et al. Fecal Cyclooxygenase 2 Plus Matrix Metalloproteinase 7 mRNA Assays as a Marker for Colorectal Cancer Screening , 2009, Cancer Epidemiology Biomarkers & Prevention.
[15] T. Leung,et al. Detection and characterization of placental microRNAs in maternal plasma. , 2008, Clinical chemistry.
[16] A. Verbeek,et al. False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening , 2009, International journal of cancer.
[17] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[18] Yonggoo Kim,et al. Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen. , 2003, Annals of clinical and laboratory science.
[19] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[20] M. A. van de Wiel,et al. MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression , 2009, British Journal of Cancer.
[21] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[22] D. Sargent,et al. Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia , 2008, Annals of Internal Medicine.
[23] Michael Z Michael,et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. , 2003, Molecular cancer research : MCR.
[24] H. Baba,et al. MicroRNA Expression Profiling of Exfoliated Colonocytes Isolated from Feces for Colorectal Cancer Screening , 2010, Cancer Prevention Research.
[25] H. Sugimura,et al. Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening. , 2004, Gastroenterology.
[26] S. Kanaoka,et al. Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer , 2010, British Journal of Cancer.
[27] J. Lupton,et al. Quantification of human intestinal gene expression profiles using exfoliated colonocytes: a pilot study , 2003, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[28] X. Agirre,et al. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues , 2006, Molecular Cancer.
[29] Brian S. Roberts,et al. The colorectal microRNAome. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[30] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[31] C. Boland,et al. Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[32] George A Calin,et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.